Previous close | 17.80 |
Open | 18.02 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 17.90 - 17.90 |
52-week range | 13.09 - 102.00 |
Volume | |
Avg. volume | 7,267 |
Market cap | 3.349B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.21 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 72.97 |
CureVac N.V. ( NASDAQ:CVAC ) shareholders (or potential shareholders) will be happy to see that insider Dietmar Hopp...
Shareholders in CureVac N.V. ( NASDAQ:CVAC ) may be thrilled to learn that the analysts have just delivered a major...
My name is Sarah Fakih, and I'm the vice president of corporate communications and investor relations at CureVac. On the call with me are Franz-Werner Haas, the chief executive officer of CureVac, Klaus Edvardsen, our chief development officer, and Pierre Kemula, chief financial officer of CureVac.